http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107474011-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f261d1abe09c80caff60d34649a4c19
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-58
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-48
filingDate 2017-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fed08ecb5d29e7d7556235c045746947
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7ce758960057e2e1d102707d873f335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da474d131a7a377288f449579d4aca73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75dada2b6c10bec09ac11b293dbff77f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fd0d38bc821de1ba8a7899ce195d6fc
publicationDate 2017-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107474011-A
titleOfInvention A class of 2-phenyl-4-styrylpyridine LSD1 inhibitors, its preparation method and application
abstract The invention discloses a class of LSD1 inhibitors with a 2-phenyl-4-styrylpyridine structure, a preparation method thereof and an application in the preparation of antitumor drugs, belonging to the technical field of medicinal chemistry. Compounds of the present invention have the general formula: In vitro LSD1 enzyme inhibitory activity and antitumor activity experiments have proved that this type of compound has obvious inhibitory effect on tumor cells by inhibiting the activity of LSD1, and can be used as a lead compound for further development and applied to the preparation of antitumor drugs.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108689960-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111592487-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111592487-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108689960-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113444038-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113444069-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110759855-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113527195-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021004610-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113527195-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022214303-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110172037-A
priorityDate 2017-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106045881-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014183221-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468002026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468041042
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455649932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468358157

Total number of triples: 45.